Joseph R. Tamayo

Joseph R. Tamayo serves as the Vice President of Regulatory and Quality at Theradaptive since April 2023, specializing in recombinant proteins for medical applications. With extensive experience as an Independent Regulatory, Quality, and Clinical Consultant since 2000, Joseph Tamayo has guided international and domestic regulatory strategies for Class III implantable and hybrid technologies. Previous leadership roles include Vice President of Operations at Silara Medtech and Osseon Therapeutics, and Vice President of Regulatory Affairs and Quality Assurance at CeloNova BioSciences and Medlogics Device Corporation. Joseph Tamayo's expertise encompasses regulatory submissions, quality system compliance, and clinical oversight across various medical device sectors, supported by a Bachelor of Science degree in Biological Sciences from Loyola Marymount University.